BioVid Corporation

What BioVid Corporation does

BioVid Corporation is a privately held life sciences consultancy founded in 1998 and headquartered in Bristol, Pennsylvania, with 11–50 employees. The firm provides primary market research and strategic consulting services to global biopharmaceutical manufacturers, biotechnology companies, medical device firms, diagnostics companies, and pre-commercial life sciences startups, spanning Phase 1 through end-of-product-lifecycle engagements. Its core commercial focus is decoding the pre-conscious and emotional drivers of physician, patient, and payer behavior to produce market access strategy, demand forecasting, segmentation, message optimization, and clinical trial acceleration outputs.

The company's underlying technology stack integrates behavioral science and cognitive psychology with a proprietary AI platform called CIAIRA™. CIAIRA™ powers Emotivate™ (emotion measurement across 70+ emotional responses) and DemandDefender™ (validated peak share forecasting benchmarked against 500+ studies, claimed accurate within a few percentage points in 90% of validated cases). Complementary proprietary methodologies include IQuus® (pre-conscious cognitive style segmentation), MindFit™ (HCP decision-making analysis), Ready Willing & Able™ (physician prescribing drivers), and Sentient Segmentation™ (durable value-based segmentation). Specialized Centers of Excellence have been built around Oncology (launched February 2026), Clinical Trials (Trial Site Typing, Ranking, and Patient Process Repair), Prediction (Goldilocks participant selection), and Market Access (covering cell and gene therapy and ATMP developers).

BioVid operates a project-based professional services model with bespoke engagements initiated via RFP, direct outreach, or industry events. There is no disclosed pricing, no self-serve channel, and no marketplace distribution. Go-to-market relies on enterprise field sales led by named practice leads and senior advisors (including a U.K.-based Global Market Access Practice Lead with three decades of experience across GSK, AstraZeneca, Novartis, IQVIA, Clarivate, and Evidera/Thermo Fisher). Marketing is built on thought leadership content (a Cognitive Equations Dictionary, an oncology and market access blog, multimedia) and active presence at ASCO, World EPA Congress, BIO-Europe, and BIO International. No external funding rounds, M&A activity, or disclosed revenue figures are present in the available data.

Name

BioVid Corporation

Legal name

BioVid Corporation

Website

https://biovid.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

BioVid Corporation is a privately held life sciences consultancy founded in 1998 that delivers behavioral science and proprietary AI-powered (CIAIRA™) market research, demand forecasting, segmentation, market access, and clinical trial services to global pharmaceutical, biotechnology, medical device, and diagnostics clients.

Ownership category

akta.pro rank

Product category

Life Sciences Behavioral Research and Consulting

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLACAOAO

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

SECONDARYHLAGAJAO

AI/ML Platforms for Drug Discovery & Experiment Optimization

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAGAJAL

Regulatory Information Management (RIM) & Submission Publishing Software

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Behavioral market research
• Pharmaceutical consulting services
• Market access strategy
• Commercial market research
• Clinical trial optimization

Headquarters

HQ city

Bristol

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Strategic Consulting Services: BioVid provides strategic consulting engagements to life science organizations, including commercial market research and market access consulting. Services span from Phase 1 through product lifecycle, delivered by practice leads and senior advisors. Engagements are project-based with direct client relationships.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

BioVid Corporation delivers primary market research and strategic consulting services to pharmaceutical, biotechnology, medical device, and diagnostics organizations, combining behavioral science and cognitive psychology with its proprietary CIAIRA™ AI platform to decode pre-conscious and emotional drivers of customer behavior. The firm sells named platforms and methodologies (Emotivate™, DemandDefender™, IQuus®, MindFit™, Sentient Segmentation™, Ready Willing & Able™) alongside three Centers of Excellence (Market Access, Clinical Trial, Oncology) that deliver demand forecasting, segmentation, message optimization, market access strategy, and clinical trial acceleration across the product lifecycle from Phase 1 through end of life.

Product overview

BioVid Corporation is a life sciences consultancy offering a portfolio of science-based products and services centered on behavioral science and AI. The core offerings include AI-powered platforms (Emotivate™, DemandDefender™, CIAIRA™), proprietary research methodologies (IQuus®, MindFit™, Sentient Segmentation™, Ready Willing & Able™), and specialized consulting services (Market Access Strategy, Clinical Trial Center of Excellence, Oncology Center of Excellence). These products work together as an integrated system: CIAIRA™ serves as the proprietary AI engine powering Emotivate™ for emotion measurement and DemandDefender™ for demand forecasting, while IQuus® and MindFit™ provide message optimization and cognitive insight services, all supported by specialized Centers of Excellence in oncology and clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Emotivate™ An emotion science platform that uses proprietary AI (CIAIRA™) to measure 70+ emotional responses and identify which campaign elements activate behavior. Bridges research and real-world performance by optimizing communications for maximum behavioral impact; for life sciences commercial and marketing teams.
• DemandDefender™ A behavioral science-based product demand platform that integrates proprietary AI (CIAIRA™) and benchmarks from 500+ studies to deliver validated peak share demand forecasts. Uncovers emotional drivers, manages bias, and provides actionable insights for commercial strategy.
• Ready, Willing & Able™ A behavioral science methodology that reveals hidden drivers and barriers behind physician prescribing using motivational interviewing techniques to pinpoint true motivators, enabling targeted strategies that move physicians from hesitation to commitment.
• MindFit™ A cognitive psychology-based solution that uncovers both conscious and unconscious drivers of HCP decision-making using techniques like Cognitive Walks and Debate-Style Dyads to surface hidden biases and ensure messages resonate.
• Sentient Segmentation™ A modernized segmentation process that goes beyond surface segmentation by revealing customers' core values, motivations, and drivers, creating durable, actionable segments that predict future behavioral shifts even as markets change.
• IQuus® A proprietary process that measures marketing message persuasion by segmenting on pre-conscious cognitive styles, not just attitudes or psychographics, enabling tailored messaging that boosts credibility, engagement, and call-to-action metrics.
• CIAIRA™ BioVid's proprietary AI platform that integrates behavioral science and cognitive psychology to measure emotional responses, identify behavioral drivers, and generate validated demand forecasts; powers Emotivate™ and DemandDefender™ under an "AI in the Human Loop" architecture.
• Market Access Strategy Services Strategic market access consulting partnering with clients at global and national levels to support assets from Phase 1 through product lifecycle, with deep expertise in launch excellence, rare disease, cell and gene therapy, and ATMPs.
• Clinical Trial Center of Excellence Three offerings — Trial Site Typing, Trial Site Ranking, and Patient Process Repair — that apply cognitive and behavioral science with advanced analytics to mitigate financial and timeline risks in clinical trial research.
• Oncology Center of Excellence A centralized hub providing specialized capabilities in market research, market access, competitive intelligence, strategic planning, and insight generation across all oncology segments, including ADC and cell/gene therapy modalities.

Quantifiable outcome

• Accurately estimates in-market peak share to within a few percentage points in 90% of validated cases
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature11 records

Partnerships

One partnership is on record.

• SermominorOthersBioVid partnered with Sermo for independent research studies, utilizing Sermo's RealTime™ platform for data collection. The partnership enabled BioVid to conduct survey research with a turnaround time of less than 24 hours, supporting studies on patient hostility and physician experience in medical care.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Clarivate: Provides market access and commercial consulting to pharma via its Decision Resources Group and Clarivate Analytics units. Several BioVid market access leaders previously held senior roles at Clarivate.
• IQVIA: Global leader in life sciences commercial market research, market access, and consulting. BioVid competes for the same enterprise pharma clients, and multiple BioVid senior leaders are former IQVIA executives.
• Evidera (Thermo Fisher Scientific): Pharma market access and HEOR consulting arm of Thermo Fisher. Directly overlaps BioVid's market access practice; BioVid's Global Market Access Lead previously served as VP & GM of Consulting at Evidera.
• ZS Associates: Large management consulting firm dedicated to life sciences commercial strategy, sales, and marketing. Competes with BioVid for pharma commercial market research and demand forecasting engagements.
• Kantar Health: Healthcare-focused market research and consulting practice within Kantar. Directly comparable offering to BioVid's commercial market research and oncology insights work.
• Ipsos Healthcare: Pharma market research division of Ipsos serving global biopharma with primary market research and advisory services. Comparable scale and client overlap with BioVid.
• Trinity Partners: Boutique life sciences strategy consulting firm focused on commercial strategy, market access, and oncology. Closest match to BioVid by firm size, specialty focus, and target buyer.

Broad incumbents

• Guidehouse (formerly Navigant): Large professional services firm with a life sciences practice covering market access, HEOR, and commercial strategy. Broader portfolio but competes in BioVid's core segments.
• Syneos Health Consulting: Combined clinical and commercial services organization offering pharma consulting including market access and behavioral science. Broader scope than BioVid but overlapping commercial offerings.
• Charles River Associates (CRA): Economic and business consulting firm with a Life Sciences practice covering commercial strategy, pricing, and market access. Competes for similar enterprise pharma advisory engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biovid-corp.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioVid Corporation